A 2022 dose-response RCT (Yi et al., Geroscience) at 300/600/900 mg/day raised NAD+ dose-dependently with no safety issues at 60 days
While BPC-157 is generally considered safe, it is crucial to prioritize your safety and consult with a healthcare professional before starting any new treatment
However, you must disclose all current medications, supplements, digestive aids, and GI treatments to our physicians during consultation
One or more items could not be added to cart due to certain restrictions
Its great to want to optimize your health, but dont skip the basics and just turn to IV vitamin therapy, she emphasizes
Broader peptide landscape Beyond BPC-157 and TB-500, numerous peptides offer regenerative properties